You have HIPAA / SOC2 compliance experience.Familiarity with Typescript, Hasura, GraphQL, and Postgres.Experience improving the monitoring and observability of an application.Experience with infrastructure as code (Terraform, Pulumi).Experience managing cloud-based infrastructure (AWS).Experience with JavaScript, Node.js, and Postgres.2+ years of software development experience.You’ll join our on-call rotation, participate in code reviews, and share your knowledge with other engineers. You'll monitor performance and errors in production to build a scalable system. You’ll write unit tests, end-to-end tests, and ensure our platform is stable.
You’ll help build a performant, secure, extensible platform for our web and mobile applications and monitor those systems. We use TypeScript, Node.js, React Native, Hasura, Postgres, and GraphQL to build our mobile & desktop apps, website, and backend. You’ll work on a fully remote product team with other engineers, product managers, and product designers based in the US.Įveryone on the engineering team can work across the stack (although some specialize). We’re looking for a mid-level engineer to help us build the infrastructure powering Brave Care OS-the suite of tools (React Native apps) that run our clinics. This is a full-time, remote position (US only) at a fast-growing startup.
We have an industry-leading NPS of 90 (average is 60 in healthcare), have raised $45MM from mission-aligned social impact investors, and are led by a seasoned executive team with a previous exit in healthcare. We’re one of the best-led and well-funded healthcare startups. We’re rebuilding the entire pediatric healthcare process-from how clinics are designed and managed, to the operating system that powers pediatric clinics, to the apps that connect parents to their doctors. We believe all children deserve excellent care and all parents deserve a healthcare process they can understand. We’re a team of technologists, doctors, and parents working to ensure that every child reaches their full potential.
0 kommentar(er)
